Publication | Open Access
Preschool Assessment of Preterm Infants Treated With Darbepoetin and Erythropoietin
76
Citations
30
References
2016
Year
ESA-treated infants had better cognitive outcomes and less developmental impairment at 3.5 to 4 years of age compared with placebo-treated infants. ESAs show promise in improving long-term cognitive outcomes of infants born prematurely.
| Year | Citations | |
|---|---|---|
Page 1
Page 1